Phase
Condition
Stimulant Use Disorder
Treatment
Active TMS
Sham TMS
Clinical Study ID
Ages 21-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 21-65 years inclusive;
Meets DSM-5 criteria for past-year moderate or severe methamphetamine use disorder;
By Timeline Follow Back endorses at least 10 days of methamphetamine use out of thelast month;
Provides a urine drug screen positive for methamphetamine;
Able to provide informed consent;
No change in current psychiatric medication regimen, or medication free, for atleast 4 weeks prior to study entry;
Adequate English proficiency for study consent, and completion of the studyinstruments.
Exclusion
Exclusion Criteria:
Lifetime non-substance-induced psychotic disorders, schizophrenia, schizoaffectivedisorder or bipolar disorder defined by DSM-5;
Current diagnosis of DSM-5 drug use disorder other than stimulant, cannabis ornicotine use disorder;
Non-substance-induced manic episode within the past 3 years or major depressiveepisode in the past year;
Current clinically significant neurological disorder or medical illness, includinghistory of seizures, cardiovascular disease/cardiac event, which in the opinion ofthe study physician would make study participation unsafe;
Presence of a clinically significant abnormality on baseline MRI;
Inability to have an MRI;
Currently breastfeeding, is currently pregnant or lack of use of effectivecontraception in women of childbearing age, as assessed by urine pregnancy test andself-report (participants will consent to continue effective contraceptives duringthe study);
Active criminal justice involvement (i.e., any unresolved legal problems that couldjeopardize continuation or completion of the study);
History of head injury with loss of consciousness for more than 15 minutes;
Diagnosis of dementia;
Prescribed benzodiazepines or anticonvulsants;
Currently enrolled in formal substance use disorder treatment;
Metal implants or non-removable metal objects above the waist;
Lifetime history of prior clinical treatment with TMS;
Serious risk of suicide or homicide;
Unable/unwilling to follow the study procedures;
History of intractable migraine;
Assessed to be at risk for alcohol or opioid withdrawal.
Study Design
Study Description
Connect with a study center
University of Colorado Anschutz Medical Campus
Aurora, Colorado 80045
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.